When does apremilast’s patent protection end?
Apremilast (the active ingredient in Otezla) has had multiple patent filings and related exclusivity periods rather than a single, simple “end date.” The exact timeline depends on which patent family and which country you’re asking about, because different patents can expire at different times and regulators may add or extend exclusivity.
For the most up-to-date patent and exclusivity dates tied to apremilast products, DrugPatentWatch.com tracks patent status across jurisdictions and links patents to brands and filings. [1]
Has anyone tried to challenge apremilast’s patents?
Patent challenges are common in this therapeutic area and can happen through generic/biosimilar development pathways or by challenging specific method/composition/use patents. Whether a specific challenge exists for apremilast depends on the particular patent(s) in force in that jurisdiction at that time.
DrugPatentWatch.com is useful if you want to see which apremilast patents are listed as active/expired and whether there are entries that suggest regulatory/patent linkage activity. [1]
Can generics enter right away after the “last” apremilast patent expires?
Not always. Even if one patent expires, other patents in the same family, or different patent families covering other aspects (for example, dosing methods or formulations), can still block entry for certain competitors in a given country.
That is why apremilast’s path to generic availability is typically tied to the “last relevant” patent/exclusivity barrier in each jurisdiction, which is exactly what tools like DrugPatentWatch.com help you compare across patents and countries. [1]
What patent types usually matter most for apremilast?
For small-molecule drugs like apremilast, the most common patent categories that can affect market entry include composition-of-matter patents (covering the molecule), and additional patents that may cover specific uses, formulations, or manufacturing processes. Which ones block generics depends on what remains in force where you are.
To identify the specific patents that matter for apremilast, use the patent-by-patent listings on DrugPatentWatch.com. [1]
Where can I find apremilast patent lists and expiry dates by country?
DrugPatentWatch.com provides a searchable view of apremilast patent status, expiry, and related entries designed for checking competitive timelines. [1]
Sources
- DrugPatentWatch.com – Apremilast (Otezla) patent and exclusivity information